Zobrazeno 1 - 7
of 7
pro vyhledávání: '"AA Zhernyakova"'
Autor:
EV Karyagina, S.V. Gritsaev, AV Chechetkin, IM Zapreeva, II Kostroma, Elena I. Stepchenkova, N.Yu. Semenova, S.S. Bessmeltsev, AA Zhernyakova, Zh.Yu. Sidorova
Publikováno v:
Clinical oncohematology. 14:73-79
Background. Autologous hematopoietic stem cell transplantation (auto-HSCT) is an indispensable treatment stage in patients with newly diagnosed multiple myeloma (MM) who are, based on age and health status, eligible for high-dose chemotherapy with su
Autor:
AV Chechetkin, Svetlana Pavlovna Svitina, S.I. Kapustin, II Kostroma, Zh.Yu. Sidorova, Zh V Chubukina, S.S. Bessmeltsev, AA Zhernyakova, S.V. Gritsaev
Publikováno v:
Clinical oncohematology. 14:340-346
Aim. To assess polymorphism value of interleukins (IL6, IL1B, IL10) and tumor necrosis factor α (TNF) genes in multiple myeloma (MM) patients who received autologous hematopoietic stem cell transplantation (auto-HSCT). Materials & Methods. The study
Autor:
II Kostroma, AV Chechetkin, Elena I. Stepchenkova, S.P. Svitina, AA Zhernyakova, Zh.Yu. Sidorova, N.Yu. Semenova, S.S. Bessmeltsev, S.V. Gritsaev, R.R. Sabitova
Publikováno v:
Clinical oncohematology. 14:333-339
Aim. To assess the rate of cases without antitumor response quality improvement after high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM). To assess the rate of allelic variants o
Autor:
II Kostroma, AV Chechetkin, AA Zhernyakova, IM Zapreeva, V.N. Chebotkevich, Gritsaev Sv, SS Bessmeltsev
Publikováno v:
Clinical oncohematology. 13:289-294
Background. There exist different data on how the administration of granulocyte colony-stimulating factor (G-CSF) after autologous hematopoietic stem cell transplantation (auto-HSCT) affects the duration of post-transplantation agranulocytosis in mul
Autor:
Tiranova Sa, EV Karyagina, Gritsaev Sv, ZhV Chubukina, Irina Martynkevich, SS Bessmeltsev, II Kostroma, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, AA Zhernyakova, AV Chechetkin, IM Zapreeva
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 282-288 (2019)
Background. In multiple myeloma (MM) treatment a single autologous hematopoietic stem cell transplantation (auto-HSCT) is preceded by conditioning regimens aimed at intensifying cytoreductive effect. In the course of ongoing search for combined condi
Autor:
Gritsaev Sv, SS Bessmeltsev, Transfusiology, ya Sovetskaya str., Saint Petersburg, Russian Federation, Tiranova Sa, ZhV Chubukina, II Kostroma, AV Chechetkin, IM Zapreeva, AA Zhernyakova, NYu Semenova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 1, Pp 32-36 (2018)
Background. The success of autologous hematopoietic stem cell transplantation (auto-HSCT) depends on the speed of transplant engraftment which in turn is affected by the count of harvested and infused hematopoietic stem cells (HSC). Aim. To identify
Autor:
LB Polushkina, S S Bessmeltsev, Kudrat Abdulkadyrov, AV Chechetkin, VA Shuvaev, Potikhonova Na, MN Zenina, SV Voloshin, Irina Martynkevich, DI Shikhbabaeva, Irina Zotova, VYu Udal’eva, AA Zhernyakova, Fominykh
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 3, Pp 402-408 (2017)
Background & Aims. The presence of different molecular genetic markers of clonality (mutations in JAK2, MPL, CALR) or their absence (triple negative status, TN) in essential thrombocythemia (ET) indicates a biological heterogeneity of the disease and